The University of Chicago Header Logo

Connection

Simon Hayward to Humans

This is a "connection" page, showing publications Simon Hayward has written about Humans.
Connection Strength

0.480
  1. TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease. Nat Commun. 2022 04 19; 13(1):2133.
    View in: PubMed
    Score: 0.025
  2. Immunotherapeutic Response in Tumors Is Affected by Microenvironmental ROS. Cancer Res. 2020 05 01; 80(9):1799-1800.
    View in: PubMed
    Score: 0.022
  3. Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment. Prostate. 2020 02; 80(2):173-185.
    View in: PubMed
    Score: 0.021
  4. Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients. Prostate. 2019 02; 79(3):259-264.
    View in: PubMed
    Score: 0.020
  5. Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo. Differentiation. 2017 Jul - Aug; 96:40-48.
    View in: PubMed
    Score: 0.018
  6. Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia. Urol Clin North Am. 2016 Aug; 43(3):279-88.
    View in: PubMed
    Score: 0.017
  7. Altered TGF-a/ß signaling drives cooperation between breast cancer cell populations. FASEB J. 2016 10; 30(10):3441-3452.
    View in: PubMed
    Score: 0.017
  8. NF-?B and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. Prostate. 2016 08; 76(11):1004-18.
    View in: PubMed
    Score: 0.017
  9. NF-?B and androgen receptor variant expression correlate with human BPH progression. Prostate. 2016 Apr; 76(5):491-511.
    View in: PubMed
    Score: 0.016
  10. Isolation and analysis of discreet human prostate cellular populations. Differentiation. 2016 Apr-Jun; 91(4-5):139-51.
    View in: PubMed
    Score: 0.016
  11. Deficiency in metabolic regulators PPAR? and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration. Am J Pathol. 2013 Feb; 182(2):449-59.
    View in: PubMed
    Score: 0.013
  12. Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium. Prostate. 2013 Apr; 73(5):476-88.
    View in: PubMed
    Score: 0.013
  13. Targeting the tumor stroma as a novel therapeutic approach for prostate cancer. Adv Pharmacol. 2012; 65:267-313.
    View in: PubMed
    Score: 0.012
  14. PPAR?: a molecular link between systemic metabolic disease and benign prostate hyperplasia. Differentiation. 2011 Nov-Dec; 82(4-5):220-36.
    View in: PubMed
    Score: 0.012
  15. Altered TGF-ß signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res. 2011 Feb 15; 71(4):1272-81.
    View in: PubMed
    Score: 0.012
  16. Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells. Stem Cells. 2010 Feb; 28(2):344-56.
    View in: PubMed
    Score: 0.011
  17. Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer. PLoS One. 2009 Dec 21; 4(12):e8384.
    View in: PubMed
    Score: 0.011
  18. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol. 2010 Feb; 21(1):33-9.
    View in: PubMed
    Score: 0.011
  19. Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression. Cancer Res. 2007 Sep 01; 67(17):8188-97.
    View in: PubMed
    Score: 0.009
  20. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res. 2007 May 01; 67(9):4244-53.
    View in: PubMed
    Score: 0.009
  21. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate. 2005 Jul 01; 64(2):149-59.
    View in: PubMed
    Score: 0.008
  22. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate. 2005 Jun 01; 63(4):369-84.
    View in: PubMed
    Score: 0.008
  23. Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia. Front Immunol. 2024; 15:1494476.
    View in: PubMed
    Score: 0.008
  24. Human prostate organoid generation and the identification of prostate development drivers using inductive rodent tissues. Development. 2023 07 01; 150(13).
    View in: PubMed
    Score: 0.007
  25. Quantitation of apoptotic activity following castration in human prostatic tissue in vivo. Prostate. 2003 Feb 15; 54(3):212-9.
    View in: PubMed
    Score: 0.007
  26. Fibroblast heterogeneity in prostate carcinogenesis. Cancer Lett. 2022 01 28; 525:76-83.
    View in: PubMed
    Score: 0.006
  27. Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells. Lab Invest. 2021 07; 101(7):921-934.
    View in: PubMed
    Score: 0.006
  28. Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression. Nat Ecol Evol. 2020 06; 4(6):870-884.
    View in: PubMed
    Score: 0.006
  29. Propagation of human prostate tissue from induced pluripotent stem cells. Stem Cells Transl Med. 2020 07; 9(7):734-745.
    View in: PubMed
    Score: 0.005
  30. Lipid droplet velocity is a microenvironmental sensor of aggressive tumors regulated by V-ATPase and PEDF. Lab Invest. 2019 12; 99(12):1822-1834.
    View in: PubMed
    Score: 0.005
  31. DGAT1 Inhibitor Suppresses Prostate Tumor Growth and Migration by Regulating Intracellular Lipids and Non-Centrosomal MTOC Protein GM130. Sci Rep. 2019 02 28; 9(1):3035.
    View in: PubMed
    Score: 0.005
  32. PEDF regulates plasticity of a novel lipid-MTOC axis in prostate cancer-associated fibroblasts. J Cell Sci. 2018 07 11; 131(13).
    View in: PubMed
    Score: 0.005
  33. Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin. J Cell Biol. 2017 11 06; 216(11):3799-3816.
    View in: PubMed
    Score: 0.005
  34. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Prostate. 2017 Aug; 77(11):1213-1220.
    View in: PubMed
    Score: 0.005
  35. Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ. Breast Cancer Res. 2017 05 15; 19(1):56.
    View in: PubMed
    Score: 0.004
  36. Genome-wide analysis of AR binding and comparison with transcript expression in primary human fetal prostate fibroblasts and cancer associated fibroblasts. Mol Cell Endocrinol. 2018 08 15; 471:1-14.
    View in: PubMed
    Score: 0.004
  37. Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo. Oncotarget. 2016 10 25; 7(43):70404-70419.
    View in: PubMed
    Score: 0.004
  38. Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations. Mol Cancer Res. 2016 Apr; 14(4):374-84.
    View in: PubMed
    Score: 0.004
  39. Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia. Endocrinology. 2016 Mar; 157(3):1094-109.
    View in: PubMed
    Score: 0.004
  40. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration. BMC Cancer. 2015 Aug 13; 15:584.
    View in: PubMed
    Score: 0.004
  41. Glucocorticoids suppress renal cell carcinoma progression by enhancing Na,K-ATPase beta-1 subunit expression. PLoS One. 2015; 10(4):e0122442.
    View in: PubMed
    Score: 0.004
  42. Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion. J Biol Chem. 2015 Mar 27; 290(13):8271-82.
    View in: PubMed
    Score: 0.004
  43. Stromal androgen receptor in prostate development and cancer. Am J Pathol. 2014 Oct; 184(10):2598-607.
    View in: PubMed
    Score: 0.004
  44. Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network. Prostate. 2014 May; 74(6):669-79.
    View in: PubMed
    Score: 0.004
  45. ALCAM/CD166 is a TGF-ß-responsive marker and functional regulator of prostate cancer metastasis to bone. Cancer Res. 2014 Mar 01; 74(5):1404-15.
    View in: PubMed
    Score: 0.004
  46. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells. Eur Urol. 2013 Nov; 64(5):753-61.
    View in: PubMed
    Score: 0.003
  47. Reduction of pro-tumorigenic activity of human prostate cancer-associated fibroblasts using Dlk1 or SCUBE1. Dis Model Mech. 2013 Mar; 6(2):530-6.
    View in: PubMed
    Score: 0.003
  48. The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor. Mol Cell Biol. 2012 Aug; 32(16):3190-202.
    View in: PubMed
    Score: 0.003
  49. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. J Clin Invest. 2012 May; 122(5):1907-19.
    View in: PubMed
    Score: 0.003
  50. Role for stromal heterogeneity in prostate tumorigenesis. Cancer Res. 2011 May 15; 71(10):3459-70.
    View in: PubMed
    Score: 0.003
  51. E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo. Proc Natl Acad Sci U S A. 2011 Jan 11; 108(2):704-9.
    View in: PubMed
    Score: 0.003
  52. Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia. Prostate. 2011 Feb 15; 71(3):305-17.
    View in: PubMed
    Score: 0.003
  53. The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach. Cancer Res. 2009 Sep 01; 69(17):7111-20.
    View in: PubMed
    Score: 0.003
  54. Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelial-mesenchymal transition and inhibition of PI3K pathway in prostate cancer. Prostate. 2009 Mar 01; 69(4):428-42.
    View in: PubMed
    Score: 0.003
  55. Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem. 2008 Oct 10; 283(41):27957-27972.
    View in: PubMed
    Score: 0.002
  56. A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. PLoS One. 2008 Jul 02; 3(7):e2572.
    View in: PubMed
    Score: 0.002
  57. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res. 2008 Jun 15; 68(12):4709-18.
    View in: PubMed
    Score: 0.002
  58. Down-regulation of p57Kip2 induces prostate cancer in the mouse. Cancer Res. 2008 May 15; 68(10):3601-8.
    View in: PubMed
    Score: 0.002
  59. Steroid hormones stimulate human prostate cancer progression and metastasis. Int J Cancer. 2006 May 01; 118(9):2123-31.
    View in: PubMed
    Score: 0.002
  60. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res. 2005 Nov 15; 65(22):10423-30.
    View in: PubMed
    Score: 0.002
  61. An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Lab Invest. 2005 Nov; 85(11):1392-404.
    View in: PubMed
    Score: 0.002
  62. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Cancer Res. 2004 Aug 01; 64(15):5489-95.
    View in: PubMed
    Score: 0.002
  63. Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett. 2004 Apr 15; 207(1):79-87.
    View in: PubMed
    Score: 0.002
  64. Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer. 2003 Oct 20; 107(1):1-10.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.